Medtronic plc. vs Merck & Company, Inc. — Stock Comparison
Medtronic plc. (MDT) and Merck & Company, Inc. (MRK) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Medtronic plc. narrowly edges Merck & Company, Inc. on Q·Score (7.1 vs 6.9 out of 10), led by Growth (7.9 vs 6.2) and Valuation (7.7 vs 6.4). Merck & Company, Inc. scores higher on Quality, reflecting stronger profitability and returns. Analyst consensus targets imply greater upside for MDT (+22.2%) than for MRK (+9.0%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Earnings growing 17% year-over-year on 10% revenue growth.
High-quality business with 19% return on equity and 14% profit margins.
Analyst Consensus
Fundamentals
Frequently Asked Questions
MDT vs MRK: which stock scores better overall?
Based on Q·Score, Medtronic plc. (MDT) scores 7.1/10 versus Merck & Company, Inc. (MRK) at 6.9/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: MDT or MRK?
Medtronic plc. (MDT) scores higher on Growth (7.9/10 vs 6.2/10). Medtronic plc. reports revenue growth (9.9% YoY) while Merck & Company, Inc. reports (4.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is MDT or MRK more attractively valued?
Medtronic plc. (MDT) scores higher on Valuation (7.7/10 vs 6.4/10). MDT trades at 12.5× P/E versus MRK at 12.4×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about MDT vs MRK?
There are 26 analysts covering MDT with a consensus price target of $98.00, and 27 analysts covering MRK with a consensus target of $129.74. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: MDT or MRK?
Merck & Company, Inc. (MRK) scores higher on Quality (7.7/10 vs 6.4/10). Net profit margin: MDT at 13.2%, MRK at 13.6%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: MDT or MRK?
Medtronic plc. (MDT) scores higher on Financial Health (7/10 vs 7/10). Market beta: MDT at 0.60, MRK at 0.22. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of MDT and MRK?
Medtronic plc. (MDT) has a market capitalisation of $103.0B, while Merck & Company, Inc. (MRK) has a market cap of $294.0B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do MDT or MRK pay dividends?
MDT pays a dividend yield of 3.59%, while MRK pays a dividend yield of 2.86%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →